Isoindolinone compounds | Patent Publication Number 20230348418
US 20230348418 A1Patent NumberUS 11912682 B2
Application Number18349634
Filled DateJul 10, 2023
Priority DateNov 18, 2021
Publication DateNov 2, 2023
Original AssigneeMonte Rosa Therapeutics Inc.
Current AssigneeMonte Rosa Therapeutics Inc.
Inventor/ApplicantsAlexander Flohr
Bernhard Fasching
Thomas Ryckmans
Bernhard Fasching
Thomas Ryckmans
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.